HIMS
Get informed when a big investor buys or sells
+ FollowUndervalued by 246.1% based on the discounted cash flow analysis.
| Market cap | $7.05 Billion |
|---|---|
| Enterprise Value | $8.12 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.57 |
| Beta | 2.34 |
| Outstanding Shares | 228,357,303 |
| P/E Ratio | -631.8 |
|---|---|
| PEG | 208.51 |
| Price to Sales | 2.62 |
| Price to Book Ratio | 28.77 |
| Enterprise Value to Revenue | 3.15 |
| Enterprise Value to EBIT | -103.47 |
| Enterprise Value to Net Income | -58 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 5.21 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2832▼ 51.00% |
|---|---|
| Total Calls | 2,978,610▼ 91.70% |
| Total Puts | 843,594▼ 97.04% |
Holdings and activity of institutional investors.
| Ownership % | 22.35%▼ 43.42% |
|---|---|
| Total Invested | $1.77B▼ 42.83% |
| Investors Holding | 242▼ 246.00% |
No data
Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermato...